HES1 and osteosarcoma: Studies have shown that the increased expression of miRNA-216b can regulate the JMJD2C/HIF1α/HES1 signaling axis in osteosarcoma cells, thereby increasing cisplatin-induced apoptosis and effectively treating osteosarcoma [130].